Modelling chemotherapy effects on granulopoiesis. - Wikidata - awgldk - TriplyDB

Modelling chemotherapy effects on granulopoiesis.

Modelling chemotherapy effects on granulopoiesis.

http://www.wikidata.org/entity/Q34996295

about

Transit and lifespan in neutrophil production: implications for drug intervention.Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.Pharmacokinetic-pharmacodynamic modelling of neutrophil response to G-CSF in healthy subjects and patients with chemotherapy-induced neutropenia.

P2860

Q47253570-A5A2836A-299E-4006-8679-627BEC1F1625 Q47657705-1DD2BC1D-97C4-4DC5-944D-4D0B4BC61A7D Q48273553-A37DBDA2-EF2F-4DFE-B547-514497B29DF1

P2860

Modelling chemotherapy effects on granulopoiesis.

http://www.wikidata.org/entity/Q34996295

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Modelling chemotherapy effects on granulopoiesis.

@ast

Modelling chemotherapy effects on granulopoiesis.

@en

Modelling chemotherapy effects on granulopoiesis.

@nl

type

label

Modelling chemotherapy effects on granulopoiesis.

@ast

Modelling chemotherapy effects on granulopoiesis.

@en

Modelling chemotherapy effects on granulopoiesis.

@nl

prefLabel

Modelling chemotherapy effects on granulopoiesis.

@ast

Modelling chemotherapy effects on granulopoiesis.

@en

Modelling chemotherapy effects on granulopoiesis.

@nl

P1433

Q34996295-1955960C-C0BE-45ED-B0F6-ED665740BB22

P1476

Q34996295-56BA9A2C-6FCC-4066-A4AC-D7C5C905096E

P2093

Q34996295-0FD96C56-697A-45DC-BF99-F000D129E2F4

Q34996295-13827197-B4AA-48C3-B27B-218F2B374DEB

Q34996295-16F1F425-4E5E-4D20-B104-C8F469E552ED

P2860

Q34996295-0205351D-3650-4FB4-B1EA-B8BCF305CC72

Q34996295-0724D680-D79B-4E0C-BBFA-4079AD460769

Q34996295-08101436-3EFC-4782-BCA0-620B63199D8B

Q34996295-08F6F8B8-6294-4DF6-A86D-3F2AD66290AC

Q34996295-0C1BF7CB-854B-42E8-A938-007434AED790

Q34996295-1111433B-F3FD-4C82-90C6-5978E02D6AC4

Q34996295-130E3EF7-AC33-4C7B-9C6C-3997048818D0

Q34996295-19F5040C-39EC-43D7-B14B-AF679C7B6155

Q34996295-1A10B307-F505-4A87-B68F-9E83E5ACC9CD

Q34996295-1ADA6482-8BD9-4482-9DF4-2AC1C4AA8055

P2888

Q34996295-DDB40D2A-7235-463B-985C-817DC03A5C3F

P304

Q34996295-F5409A35-1188-4114-931A-37507198056B

P31

Q34996295-08046566-9105-420E-9A36-B46B42453E02

P356

Q34996295-B6B7E1C0-2C00-4F3F-BAC6-B535254EA273

P478

Q34996295-013C5875-E9D6-4478-956D-5CB7743719BC

P50

Q34996295-8C52BCD5-85FA-4BFA-85D4-1CF98600AD39

P577

Q34996295-5262B867-8563-46FD-A1F4-4F22342805FF

P5875

Q34996295-CE20741E-8AB2-4460-AD75-0EA88198EFD3

P6179

Q34996295-A4684B8C-3C77-482E-85C1-5575B29B425B

P698

Q34996295-F77B2561-7A58-433B-8D01-4F9539C2AA99

P921

Q34996295-0734C8A3-6D49-4A54-952F-184BA3283B3B

P932

Q34996295-94C00FA4-CFFD-451E-B5BC-5705BAFD17D1

P356

S12918-014-0138-7

P1433

BMC Systems Biology

P1476

Modelling chemotherapy effects on granulopoiesis.

@en

P2093

Markus Loeffler

http://www.w3.org/2001/XMLSchema#string

Markus Scholz

http://www.w3.org/2001/XMLSchema#string

Sibylle Schirm

http://www.w3.org/2001/XMLSchema#string

P2860

Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

The platelet-sparing effect of paclitaxel is not related to changes in the pharmacokinetics of carboplatin.

Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia.

14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.

A mathematical model of haemopoiesis as exemplified by CD34 cell mobilization into the peripheral blood.

Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma.

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.

A biomathematical model of human thrombopoiesis under chemotherapy.

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.

Leukokinetic studies. 13. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis.

P2888

s12918-014-0138-7

P304

138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12918-014-0138-7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Engel

P577

2014-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270054678

http://www.w3.org/2001/XMLSchema#string

P6179

1029877080

http://www.w3.org/2001/XMLSchema#string

P698

25539928

http://www.w3.org/2001/XMLSchema#string

P921

P932

4302124

http://www.w3.org/2001/XMLSchema#string